Home Leuprolide Appears Feasible, But Coverage Limits Access
-
By
-
Vishal R. Patel
-
Arjun Gupta
-
August 21, 2026
Clinical Report: An Inexpensive Solution to Reduce Patient Time Commitment Might Be Underutilized
Overview
A pilot study demonstrated that patients with breast cancer can self-administer leuprolide injections at home, significantly reducing travel time and wait periods. However, insurance-related barriers prevented many interested patients from participating in home administration.
Background
Hormone-dependent malignancies often require long-term treatment with hormone-based agents, necessitating frequent clinic visits for injections. This can lead to significant time burdens for patients, termed 'time toxicity.' Exploring alternatives like home administration could alleviate these burdens.
Data Highlights
In the pilot study, 24 patients were trained to self-administer leuprolide injections at home. Of these, 23 successfully self-injected. Additionally, 75% of participants continued home administration after the study, particularly those residing over 50 miles from the clinic. However, 30 out of 54 interested patients faced insurance barriers that prevented their participation, and one patient reverted to clinic administration due to high out-of-pocket costs for home injections, which could reach up to $2000.
Key Findings
23 of 24 patients successfully self-administered leuprolide injections at home after training.
Three-quarters of participants continued home injections after the study, especially those living more than 50 miles from the clinic.
Insurance barriers prevented 30 out of 54 interested patients from participating in the study.
One patient returned to clinic administration due to increased out-of-pocket costs for home injections.
Out-of-pocket expenses for home administration can reach up to $2000.
Clinical Implications
Healthcare providers should be aware of the potential for home administration of hormone therapies. Addressing insurance-related barriers is crucial.
Conclusion
The study demonstrates the feasibility of home self-injection for patients but highlights the need to address financial barriers.
Related Resources & Content
Malling et al, Source, Year -- An Inexpensive Solution to Reduce Patient Time Commitment Might Be Underutilized
optometric management — The Power of Efficient Patient Scheduling
Ophthalmology Management — Increase Efficiency and Profitability in Your Clinic
optometric management — Utilizing Staff for Patient Adherence
Ophthalmology Management — Work Smarter, Not Harder
The Power of Efficient Patient Scheduling
Increase Efficiency and Profitability in Your Clinic
Utilizing Staff for Patient Adherence
EAU - EANM - ESTRO - Guidelines on Prostate Cancer
Clinical Management of Ovarian Function Suppression in Premenopausal Women With Breast Cancer
An Overview of Long-Acting GnRH Agonists in Premenopausal Breast Cancer Patients: Survivorship Challenges and Management - PMC
Based on findings from:
The Cheapest Way to Save a Patient’s Time May Be One We Will Not Pay For
Vishal R. Patel, Arjun Gupta. Jama Network Open, 2026.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2853163
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.